Carl Zeiss Meditec AG header image

Carl Zeiss Meditec AG

AFX

Equity

ISIN DE0005313704 / Valor 1055489

Xetra (2026-03-27)
EUR 24.32-2.72%

Carl Zeiss Meditec AG
UMushroom community rating:

star star star star star
4.40 5 votes No rating yet
NegativeNeutralPositive

About company

Carl Zeiss Meditec AG, headquartered in Jena, Germany and listed on the Frankfurt Stock Exchange, is a medical-technology company focused principally on devices, software and consumables for eye care and microsurgery. Its product portfolio spans diagnostic imaging systems (including optical coherence tomography and retinal imaging), surgical platforms and visualization equipment (such as surgical microscopes and laser systems for refractive and cataract procedures), as well as intraocular lenses, disposables and clinical IT solutions that support workflow and data management. The company sells capital equipment to hospitals, eye clinics and private practices worldwide and generates recurring revenue from consumables, service contracts and software, while investing in research and regulatory approvals to maintain and extend its market position in ophthalmology and related microsurgical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-63.0%1Y
-81.9%3Y
-81.3%5Y

Performance

45.6%1Y
42.7%3Y
40.1%5Y

Volatility

Market cap

2458 M

Market cap (USD)

Daily traded volume (Shares)

221,957

Daily traded volume (Shares)

1 day high/low

47.3 / 46.28

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.40

5 votes
Performance:
starstarstarstarstar
4.20
Innovation:
starstarstarstarstar
4.80
Society:
starstarstarstarstar
4.40
Nature:
starstarstarstarstar
4.20
Luba Schoenig
Switzerland, 08 Jun 2023
star star star star star
Highly innovative company who is expected to be one of the key riders on the virtual reality glasses wave
Tonia Zimmermann
Switzerland, 06 Jun 2023
star star star star star
Big potential ahead of them given the use of their solutions in apple products
Laura Bischofberger
Switzerland, 06 Jun 2023
star star star star star
Interessante Performance über die letzten Jahre. & mit der Vorstellung vom neuen Produkt gestern durch Apple, ist ein gross Auftrag garantiert

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.82%USD 72.15
Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.96%USD 84.61
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38